First-line therapeutic strategy for patients with advanced non-small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis

• Asıl Yazarlar: Chongxiang Chen (Yazar), Chunning Zhang (Yazar), Huaming Lin (Yazar), Qianyin Liu (Yazar), Limian Wu (Yazar), Chengzhi Zhou (Yazar), Jiexia Zhang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: SAGE Publishing, 2022-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Aim: The objective of this network meta-analysis was to determine the most useful first-line therapeutic strategy for patients with advanced (IIIB/IV or relapsed) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Leu858Arg or EGFR 19del mutations. Methods: PubMed, the W...